Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Evergy Announces Third Quarter 2025 Results, Increases Quarterly Dividend and Narrows 2025 Guidance
-
TeamViewer Achieves Key FedRAMP Compliance Milestone for its DEX Platform
-
CUBE LAUNCHES INDUSTRY-LEADING COST OF COMPLIANCE REPORT 2025, HIGHLIGHTING ROLE OF AI IN TACKLING GLOBAL REGULATORY COMPLEXITY
-
Dentalcorp Reports Third Quarter 2025 Results
-
Papa Johns Announces Third Quarter 2025 Financial Results
-
Horace Mann Expands Reach to Educators Through Alumni Associations
-
MarkeTeam.ai and NorthBrix Sign Strategic Collaboration to Launch CyBrixTeam.AI Across Africa
-
Amylyx Pharmaceuticals Reports Third Quarter 2025 Financial Results
-
NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board
-
Monte Rosa Therapeutics Announces Third Quarter 2025 Financial Results and Business Updates
-
SharkNinja Reports Third Quarter 2025 Results
-
SkylineDx Wins 2025 BioTech Breakthrough Award for "Diagnostics Company of the Year"
-
U.K. Continues to Lead Europe in Shareholder Activism with 44% Year-on-Year Surge, According to Diligent Market Intelligence
-
TASE Announces an Historic Milestone -The Largest-Ever Equity Indices Update Kicks Off
-
United Homes Group, Inc. Reports 2025 Third Quarter Results
-
Donaldson to Webcast First Quarter Fiscal 2026 Earnings Conference Call
-
AAON Reports Strong Third Quarter 2025 Results Driven by Operational Improvements and Share Gains
-
PENN Entertainment and ESPN Mutually Agree to Early Termination of U.S. Online Sports Betting Agreement
-
Nexstar Media Group Reports Third Quarter Net Revenue of $1.20 Billion
-
Blue Gold Limited Opens Registration for Standard Gold Coin (SGC), Digital Token Backed by Physical Gold
-
Achieve Life Sciences Reports Third Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
-
Vistra Reports Third Quarter 2025 Results, Narrows 2025 Guidance, and Initiates 2026 Guidance
-
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF
-
NOG Reprices and Extends Its Revolving Credit Facility
-
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates
-
New Era Energy & Digital Enters into Land Option Purchase Agreement for 3,500 Acres in New Mexico for 7GW AI Data Center Hub; Marks first Wholly Owned Development, Separate from TCDC Joint Venture
-
Scientologists Across Europe Strengthen Humanitarian Work as Path to Spiritual Freedom
-
The Middleby Corporation Reports Third Quarter Results
-
Sydnexis Announces UK Approval of Ryjunea® by Partner Santen to Slow Progression of Childhood Myopia
-
Kimbell Royalty Partners Announces Third Quarter 2025 Results
-
Xeris Biopharma Posts Record Financial Results for the Third Quarter 2025
-
SharkNinja Names Adam Quigley Chief Financial Officer
-
Prowler Launches Lighthouse AI and MCP Server, Bringing Autonomous Security to DevSecOps Teams
-
BlackSky Reports Third Quarter 2025 Results
-
nubia Z80 Ultra Now Available for Global Pre-Order: Unleash Elite Gaming and Professional Photography with Snapdragon® 8 Elite Gen 5
-
Intellum and HexaLearn Partner to Deliver End-to-End, Scalable Learning and Technology Solutions
-
Shift4 Announces Third Quarter 2025 Results
-
Online Mattress Shoppers Find Greater Value and Satisfaction Than In-Store Buyers, J.D. Power Finds
-
Altice USA Changes Corporate Name and NYSE Ticker Symbol to Align with Optimum Brand
-
ConocoPhillips announces third-quarter 2025 results; increases quarterly ordinary dividend by 8% and announces preliminary 2026 guidance
-
Overland Oasis launches resupply stations for RVers, digital nomads, campers and adventure motorcyclists
-
Baker Hughes Secures Additional Order for Rio Grande LNG Expansion
-
Angel Oak Mortgage REIT, Inc. Reports Third Quarter 2025 Financial Results
-
Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET
-
Mark Cuban Cost Plus Drug Company Expands Access with Addition of Starjemza® (ustekinumab-hmny) to Give Patients More Power Over Prescription Costs
-
AstraZeneca's 9M and Q3 2025 Financial Results
-
Bio-Techne to Present at Upcoming Investor Conferences
-
LCI Industries to Participate in Upcoming Truist Conference
-
TIC Solutions Announces Upcoming Participation in Baird's 2025 Global Industrial Conference
-
Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

